Innovation

Use of Dexatromethorphan; Sodium Benzoate, Phenylacetate and Phenylbuterate to Treat Autism Associated with Increased Levels of Glutamine and Glycine.

Vanderbilt University
posted on 01/25/2010

-


Innovation Details
 

Detailed Description

File Number: MKT9944  


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact the case manager at Vanderbilt University for more information.

Request more info via email request more info
People

No people are currently associated with this innovation.


Download Technology Brief (PDF)


[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
1849

Vanderbilt University


Profile
Related Tags

Find more innovations

February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

Linda L. Restifo, M.D., Ph.D. - University of Arizona

"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."  read more...